Nanoemulsion in Management of Colorectal Cancer: Challenges and Future Prospects

The second most significant cause of cancer-related mortality and morbidity in the United States is colorectal cancer (CRC), the third most diagnosed malignancy. People over 50 have an increased risk of CRC everywhere in the world. Genetic and environmental risk factors significantly influence CRC development. Early detection is critical in the treatment and prevention of CRC. The population’s incidence rate of CRC is currently reduced by screening techniques and medicines, although recurrence of the disease may result from the cancer’s ability to spread locally. Consequently, the difficulty is in finding a different treatment for CRC. Nanotechnology is crucial for cancer treatment because it allows for the delivery of targeted chemotherapies to cancer cells directly and with greater therapeutic potency. Nanoemulsions have broad application in pharmaceutics, cosmetics, and food; their outstanding properties include enhanced dispersion of active hydrophobic components, small size, high surface area per unit volume, and improved absorption in cancer treatment. The present review highlights formulation aspects, preparation methods, and characterization techniques. We also provide a critical analysis of recent developments in nanoemulsions in colorectal cancer treatment that hold promise in delivering nanoemulsions in colorectal treatment.